- Home
- Pharmaceuticals
- 040-000-293 Oseltamivir Acid, CAS 187227-45-8
040-000-293 Oseltamivir Acid, CAS 187227-45-8
Synonym | 4R-(acetylamino)-5S-amino-3R-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid |
Type | Neuaminidase inhibitor |
Keywords | Neuaminidase, influenza |
Related products | Arbidol Hydrochloride,Oseltamivir Phosphate,Sirolimus |
- Description
Description
Description
Oseltamivir Acid Specifications
Product Name | Oseltamivir Acid |
CAS Registry Number | 187227-45-8 |
Molecular Formula | C14H24N2O4 |
Molecular Weight | 284.4 g/mol |
Purity | 98 % |
Appearance | White crystalline powder |
Package | 1oo mg-100 g |
Shelf life | 2 years |
Functions | inhibitor of neuraminidase, treating influenza |
Oseltamivir Acid Description
Oseltamivir is a specific inhibitor of neuraminidase. Its inhibitory effect on neuraminidase can inhibit the mature influenza virus from detaching from host cells, thereby inhibiting the spread of the influenza virus in the human body to play a role in treating influenza. Oseltamivir acid is the active metabolite of oseltamivir.
Oseltamivir Acid is an antiviral drug, it is used as the corresponding ethyl ester prodrug, oseltamivir, to slow the spread of influenza.
Oseltamivir Acid Functions
- Prevent viral replication: Prevent the spread of the virus in the body by inhibiting the neuraminidase enzyme in the influenza virus.
- Influenza Treatment: Used to treat and prevent influenza A and B infections.
- Reduces symptoms: Helps shorten the duration of cold symptoms and reduces their severity.
Oseltamivir Acid Applications
- Pharmaceutical anti-flu drugs
- Laboratory research
Reference:
- Govorkova, E.A., Ilyushina, N.A., McClaren, J.L., et al. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrobial Agents and Chemotherapy 53(7), 3088-3096 (2009).
- Krueger, A.C., Xu, Y., Kati, W.M., et al. Synthesis of potent pyrrolidine influenza neuraminidase inhibitors. Bioorganic & Medicinal Chemistry Letters 18(5), 1692-1695 (2008).
- Lew, W., Wu, H., Chen, X., et al. Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: Synthesis and inhibitory activity. Bioorganic & Medicinal Chemistry Letters 10(11), 1257-1260 (2000).